If granted approval by DCGI, Covaxin will become only the second vaccine after Zydus Cadila's ZyCoV-D to be granted permission for inoculating children in 2-18 age group.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/308wCQP
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Covaxin gets SEC approval: Getting the experts’ perspective
https://ift.tt/eA8V8J
No comments:
Post a Comment